| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/03/2007 | EP1738742A2 Benzyl-1,3-thiazolidine-2,4-dione compounds, compositions comprising them and use for stimulating or inducing the growth of keratinic fibres and/or for diminsihing their loss |
| 01/03/2007 | EP1738741A2 Use of benzylidene-1,3-thiazolidine-2,4-diones for favouring and/or inducing and/or stimulating the pigmentation of keratinic materials and/or for limiting their depigmentation and/or their bleaching |
| 01/03/2007 | EP1738740A2 Use of benzyl-1,3-thiazolidine-2,4-dione compounds for favouring and/or inducing and/or stimulating the pigmentation of keratinic materials and/or for limiting their depigmentation and/or their bleaching |
| 01/03/2007 | EP1738658A1 Acerola leaf extract-containing blood sugar level increase inhibitor and age formation inhibitor, and food containing them |
| 01/03/2007 | EP1737979A2 Method for diagnosing non-small cell lung cancer |
| 01/03/2007 | EP1737957A1 UNIVERSAL TARGET SEQUENCES FOR siRNA GENE SILENCING |
| 01/03/2007 | EP1737956A2 Rnai-based therapeutics for allergic rhinitis and asthma |
| 01/03/2007 | EP1737880A1 17alpha-fluoro-17beta-hydroximinomethyl steroids, a method for production thereof and pharmaceutical compositions comprising said compounds |
| 01/03/2007 | EP1737876A1 Avermectin and avermectin monosaccharide substituted in the 4"-and 4'-position respectively |
| 01/03/2007 | EP1737870A1 Thiazolopyridine derivates, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions |
| 01/03/2007 | EP1737867A1 Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof |
| 01/03/2007 | EP1737866A2 Compounds with atypical antipsychotic activity |
| 01/03/2007 | EP1737864A1 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments |
| 01/03/2007 | EP1737863A2 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors |
| 01/03/2007 | EP1737862A1 Imidazopyridine compound |
| 01/03/2007 | EP1737860A1 Selected cgrp-antagonists, their preparation processes and their use as medicaments |
| 01/03/2007 | EP1737859A1 Novel crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo¬4.3.0|nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid |
| 01/03/2007 | EP1737858A1 Sulfonamides |
| 01/03/2007 | EP1737857A1 Pyrazolo[3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors |
| 01/03/2007 | EP1737856A1 Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol, and applications thereof |
| 01/03/2007 | EP1737854A1 NOVEL 2-(1-AZA-BICYCLO[2.2.2]OCT-3-yl)-2,3-DIHYDROISOINDOL-l-ONE/5,6-DIHYDRO-FURO[2,3-c]PYRROL-4ONE DERIVATIVES LIGANDS FOR ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR |
| 01/03/2007 | EP1737853A1 3-(diheteroarylmethylene)-8-azabicyclo¬3.2.1|octane and 3-((aryl)(heteroaryl)methylene)-8-azabicyclo¬3.2.1|octane derivatives |
| 01/03/2007 | EP1737852A2 Polycyclic pyridines as potassium ion channel modulators |
| 01/03/2007 | EP1737851A1 Tetrahydrobenzazepine derivatives as modulators of dopamine d3 receptors (antipsychotic agents) |
| 01/03/2007 | EP1737849A1 Compounds having morpholinyl and piperidinyl groups for use as glyt1 inhibitors |
| 01/03/2007 | EP1737848A1 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone hydrochloride as an inhibitor of mast cell tryptase |
| 01/03/2007 | EP1737847A2 Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol |
| 01/03/2007 | EP1737846A1 New process for the preparation of diazine derivatives |
| 01/03/2007 | EP1737845A2 Disalt inhibitors of il-12 production |
| 01/03/2007 | EP1737843A1 Inhibitors of akt activity |
| 01/03/2007 | EP1737842A1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs |
| 01/03/2007 | EP1737840A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 01/03/2007 | EP1737839A1 Novel alkyne compounds having an mch-antagonistic effect and medicaments containing said compounds |
| 01/03/2007 | EP1737838A1 Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists |
| 01/03/2007 | EP1737836A1 Antiviral agents |
| 01/03/2007 | EP1737835A2 Derivatives of dihydronepetalactone and method for preparation |
| 01/03/2007 | EP1737832A1 Compounds derived from 4-anilinequinazolines with adenosine-kinase inhibitor properties |
| 01/03/2007 | EP1737831A1 Neurologically-active compounds |
| 01/03/2007 | EP1737830A1 Tri-substituted ureas as cytokine inhibitors |
| 01/03/2007 | EP1737826A1 Alpha-4 integrin mediated cell adhesion inhibitors for the treatment or prevention of inflammatory diseases |
| 01/03/2007 | EP1737825A1 Geldanamycin and derivatives inhibit cancer invasion and identify novel targets |
| 01/03/2007 | EP1737824A2 Novel alkyne compounds having an mch-antagonistic effect, and medicaments containing said compounds |
| 01/03/2007 | EP1737823A2 Novel alkyne compounds with an mch-antagonistic action and medicaments comprising said compounds |
| 01/03/2007 | EP1737822A1 N-'4-4(4-morpholinyl) phenyl!-'(4-piperidinyl) methyl! carboxamide derivatives and their use as glycine transporter inhibitors |
| 01/03/2007 | EP1737821A1 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 01/03/2007 | EP1737819A1 Amino acid and peptide conjugates of arylalkylic acids for cosmetic use |
| 01/03/2007 | EP1737816A1 Integrin modulators and methods for their use |
| 01/03/2007 | EP1737815A1 Thio-substituted biaryl-methanesulfinyl derivatives |
| 01/03/2007 | EP1737813A1 Androgen modulators |
| 01/03/2007 | EP1737811A1 Cetp inhibitors |
| 01/03/2007 | EP1737809A2 Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders |
| 01/03/2007 | EP1737539A1 Therapeutic combination for treatment of alzheimers disease |
| 01/03/2007 | EP1737537A1 Use of simethicone in constipated patients |
| 01/03/2007 | EP1737502A2 Polymer no donor predrug nanofiber coating for medical devices and therapy |
| 01/03/2007 | EP1737497A2 Nucleic acid aptamers conjugated to high molecular weight steric groups |
| 01/03/2007 | EP1737493A2 Inhibitors of insulin-like growth factor receptor -1 for inhibiting tumour cell growth |
| 01/03/2007 | EP1737488A1 Treatment of fungal infections |
| 01/03/2007 | EP1737482A2 Compositions and methods for treating diseases |
| 01/03/2007 | EP1737480A2 Pharmaceutical combined preparation containing a therapeutic protein |
| 01/03/2007 | EP1737474A2 Non-gmo metal amino acid chelates and non-gmo metal amino acid chelate-containing compositions |
| 01/03/2007 | EP1737473A2 Lithium combinations, and uses related thereto |
| 01/03/2007 | EP1737472A2 Effective treatment of tumors and cancer with triciribine and related compounds |
| 01/03/2007 | EP1737471A2 Pharmaceutical compositions and methods of use of lipophilic, silicon-substituted, cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs and derivatives |
| 01/03/2007 | EP1737470A2 Hypoallergenic metal amino acid chelates and metal amino acid chelate-containing compositions |
| 01/03/2007 | EP1737469A2 Methods and compositions employing 4-aminophenylacetic acid compounds |
| 01/03/2007 | EP1737468A2 Treatment of interstitial cystitis with vitamin d compounds |
| 01/03/2007 | EP1737467A1 Method and composition for treatment of skin conditions |
| 01/03/2007 | EP1737466A1 COMBINATION OF y-AMINOBUTYRIC ACID MODULATORS AND 5-HT-1b RECEPTOR ANTAGONISTS |
| 01/03/2007 | EP1737465A1 Composition and method of decreasing renal ischemic damage |
| 01/03/2007 | EP1737464A1 Use of a trioxopyrimidine for the treatment and prevention of bronchial inflammatory diseases |
| 01/03/2007 | EP1737463A1 Pyrimidines with tie2 (tek) activity |
| 01/03/2007 | EP1737462A1 Pyrimidines with tie2 (tek) activity |
| 01/03/2007 | EP1737461A1 Carboline derivatives useful in the inhibition of angiogenesis |
| 01/03/2007 | EP1737460A2 Intermittent dosing regimen for the treatment of overweight with mtp-inhibitors |
| 01/03/2007 | EP1737459A1 Imidazopyridine and imidazopyrimidine derivatives as antibacterial agents |
| 01/03/2007 | EP1737458A2 R(-)-11-hydroxyaporphine derivatives and uses thereof |
| 01/03/2007 | EP1737457A2 Use of a sphingoid base associated with nicotinic acid or a nicotinic acid amide in the form of a depigmentation agent |
| 01/03/2007 | EP1737456A1 Medicament |
| 01/03/2007 | EP1737455A1 Controlled release pharmaceutical composition of tolperisone for oral administration |
| 01/03/2007 | EP1737454A2 Method of food intake management |
| 01/03/2007 | EP1737453A2 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of skin diseases or disorders |
| 01/03/2007 | EP1737452A1 Angiogenesis-affecting compounds and methods of use thereof |
| 01/03/2007 | EP1737451A2 Monocyclic heterocycles as kinase inhibitors |
| 01/03/2007 | EP1737450A1 Aqueous composition comprising thiazole derivative |
| 01/03/2007 | EP1737449A1 Pharmaceutical composition |
| 01/03/2007 | EP1737448A1 (s) - enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases |
| 01/03/2007 | EP1737447A1 (r)-enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases |
| 01/03/2007 | EP1737446A2 Fused heterocyclic compounds |
| 01/03/2007 | EP1737445A2 Method of treating down syndrome |
| 01/03/2007 | EP1737444A1 C7 lactyloxy-substituted taxanes |
| 01/03/2007 | EP1737443A2 Use of cis-epoxyeicosantrienoic acids and inhibitors of soluble epoxide hydrolase to reduce pulmonary infiltration by neutrophils |
| 01/03/2007 | EP1737442A1 Agonists of a bitter taste receptor and uses thereof |
| 01/03/2007 | EP1737441A2 Beneficial effects of increasing local blood flow |
| 01/03/2007 | EP1737440A2 Use of ppar delta agonists for treating demyelinating diseases |
| 01/03/2007 | EP1737439A2 Calcium salts for the treatment of psoriasis, dermatitis and dandruff |
| 01/03/2007 | EP1737438A1 alpha-AMINOAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF RESTLESS LEGS SYNDROME AND ADDICTIVE DISORDERS |
| 01/03/2007 | EP1737437A1 Novel use of peptide compounds for treating pain in painful diabetic neuropathy |
| 01/03/2007 | EP1737436A1 Prevention, treatment, and amelioration of radiation induced enteritis |
| 01/03/2007 | EP1737435A2 Fluid composition used to simulate human synovial fluid |
| 01/03/2007 | EP1737434A2 Apparatus and method for transdermal delivery of fentanyl-based agents |